| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2025 - 30 Sept 2025 | 31 Oct 2025 | 61 | 6% | 67% | 27% | 4% |
| 01 Oct 2024 - 31 Mar 2025 | 29 Apr 2025 | 57 | 9% | 53% | 38% | 11% |
| 01 Apr 2024 - 30 Sept 2024 | 31 Oct 2024 | 59 | 4% | 57% | 39% | 47% |
| 01 Oct 2023 - 31 Mar 2024 | 22 May 2024 | 58 | 6% | 60% | 34% | 37% |
| 01 Apr 2023 - 30 Sept 2023 | 20 Nov 2023 | 65 | 4% | 61% | 35% | 39% |
| 01 Oct 2022 - 31 Mar 2023 | 22 May 2023 | 54 | 6% | 67% | 27% | 14% |
| 01 Apr 2022 - 30 Sept 2022 | 16 Nov 2022 | 53 | 6% | 71% | 23% | 17% |
| 01 Oct 2021 - 31 Mar 2022 | 29 Apr 2022 | 31 | 51% | 36% | 13% | 18% |
| 01 Apr 2021 - 30 Sept 2021 | 02 Nov 2021 | 53 | 6% | 71% | 23% | 14% |
| 01 Oct 2020 - 31 Mar 2021 | 05 May 2021 | 53 | 6% | 68% | 26% | 33% |
| 01 Apr 2020 - 30 Sept 2020 | 21 Oct 2020 | 59 | 6% | 68% | 26% | 18% |
| 01 Oct 2019 - 31 Mar 2020 | 22 May 2020 | 61 | 5% | 66% | 29% | 30% |
| 01 Apr 2019 - 30 Sept 2019 | 31 Oct 2019 | 57 | 5% | 66% | 29% | 21% |
| 01 Oct 2018 - 31 Mar 2019 | 18 Apr 2019 | 53 | 7% | 77% | 16% | 13% |
| 01 Apr 2018 - 30 Sept 2018 | 31 Oct 2018 | 57 | 5% | 65% | 30% | 18% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Standard payment terms are on the 28th day of the first month following the date of invoice with cleared funds following the second working day of the second month for undisputed invoices. (Average of 45 days).
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
92
The main point of contact for disputes is the Accounts Payable department who manage the approval of invoices and follow internal processes to deal with and resolve invoice queries. Disputes will be investigated by the Accounts Payable team, who will liaise with the appropriate function to resolve the query. Query invoices will be held for payment until resolved.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
AAH Pharmaceuticals Limited is a long-established company, previously named Mawson & Proctor Pharmaceuticals Limited until 1987, registered in England. Its stated business activities are the manufacture of basic pharmaceutical products and the wholesale of pharmaceutical goods. The company is part of a wider corporate structure, with Admenta UK Limited recorded as its person with significant control. It remains active, with recent Companies House filings covering accounts, confirmation statements, director appointments and registered charges. No further detail on specific product lines, customers or operational scale is provided in the available evidence.
Generated from the company's website and Companies House records. Sources: find-and-update.company-information.service.gov.uk · find-and-update.company-information.service.gov.uk